期刊文献+

细胞色素P450氧化酶基因多态性与氯吡格雷治疗冠心病效果的相关性 被引量:3

Association between CYP2C19 polymorphisms and efficacy of ciopidogrel in coronary atherosclerotic heart disease
原文传递
导出
摘要 目的 探讨老年慢性心房颤动患者血栓形成前状态的相关因素. 方法 选取2009年5月至2011年5月我院收治的老年慢性心房颤动患者142例,根据食道心脏彩色超声检查(TEE)分为血栓形成前状态组(PTS组)90例和无血栓形成前状态组(非PTS组)52例.检测两组患者的左房内径(LAD)、射血分数(LVEF)、高敏C-反应蛋白(hs-CRP)、D-二聚体(D-D)、血浆β-血小板球蛋白(β-TG)、B型利钠肽(BNP),P选择素(PS),内皮损伤标志物血管性血友病因子(vWF)和花生四烯酸(AA)诱导的血小板聚集率.多因素Logistic回归分析慢性心房颤动患者血栓形成前状态的相关因素. 结果 PTS组患者心房颤动时间、二尖瓣反流例数、hs-CRP、D-D、β-TG、BNP、PS,vWF和AA诱导的血小板聚集率分别为(6.9±1.8)年、39例(43.3%)、(7.8±1.0)mg/L、(706.6±38.1)μg/L、(147.2±21.3)μg/L、(1075.4±31.2)ng/L、(88.5±13.9)μg/L、(36.1±11.2)×10-3U/L和(27.4±12.6)%,均明显高于非PTS组患者(4.7±1.3)年、11例(21.2%)、(2.7±0.4) mg/L、(270.4±28.5)μg/L、(117.7±17.1)μg/L、(222.6±26.0)ng/L、(37.4±11.2)μg/L、(26.4±9.9)×10-3 U/L和(19.7±5.7)%,组间差异均具有统计学意义(t=4.52、11.18、15.31、31.20、4.89、166.46、22.59、14.06、5.45,均P<0.01).多因素Logistic回归分析结果显示,心房颤动时间、二尖瓣反流、hs-CRP、PS、vWF和AA诱导血小板聚集率为慢性心房颤动患者血栓形成前状态的独立危险因素(OR=3.57、2.19、2.91、3.28、2.37、1.98,均P<0.05). 结论 心房颤动时间、二尖瓣反流、血浆中hs-CRP、PS含量、vWF和AA诱导的血小板聚集率可作为老年心房颤动患者并发血栓前状态的预测因素. Objective To explore the correlation between prethrombotic state (PTS)and chronic atrial fibrillation in elderly patients,and to analyze the risk factors.Methods A total of 142 elderly patients with chronic atrial fibrillation from May 2009 to May 2011 were selected.Patients were divided into the PTS group (n =90) and no-PTS group (n =52) by transesophageal echocardiography (TEE).The left atrial diameter (LAD),left ventricular ejection fraction (LVEF),levels of high-sensitivity c reactive protein (hs-CRP),D-Dimer (D-D),β-platelet globulin (β-TG),B type brain natriuretic peptide (BNP),P-select element (PS),endothelial damage/dysfunction mark (vWF) and platelet aggregation rate-AA (PAR-AA)were determined.The related factors of prethrombotic state in elderly patients with chronic atrial fibrillation were analyzed by the multiple regression analysis.Results There were significant differences in the time of atrial fibrillation,frequency of patients with mitral regurgitation,levels of hs-CRP,D-D,β-TG,BNP,PS,vWF and PAR-AA between the PTS group and the non-PTS group [(6.9±1.8)years vs.(4.7±1.3)years,39 cases (43.3%)vs.11 cases (21.2%),(7.8±1.0)mg/L vs.(2.7±0.4)mg/L,(706.6±38.1)μg/L vs.(270.4±28.5)μg/L,(147.2± 21.3) μg/L vs.(117.7±17.1)μg/L,(1075.4±31.2)ng/L vs.(222.6±26.0)ng/L,(88.5±13.9)μg/Lvs.(37.4±11.2)μg/L,(36.1±11.2) ×10-3U/L vs.(26.4±9.9)×10-3U/L,(27.4±12.6)% vs.(19.7±5.7)%,t=4.52,11.18,15.31,31.20,4.89,166.46,22.59,14.06,5.45,respectively,all P〈0.01].Multivariate logistic regression analysis showed that the time of chronic atrial fibrillation,mitral regurgitation,levels of hs CRP,PS,vWF and PAR-AA were independent risk factors for PTS in elderly patients with atrial fibrillation (OR=3.57,2.19,2.91,3.28,2.37,1.98,respectively,all P〈0.05).Conclusions The time of atrial fibrillation,mitral regurgitation,levels of hsCRP,PS,vWf and PAR-AA are independent risk factors for PTS in elderly patients with chronic atrial
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2013年第5期483-485,共3页 Chinese Journal of Geriatrics
关键词 冠心病 细胞色素P450酶系统 多态性 单核苷酸 Coronary disease Cytochrome P-450 enzyme system Polymorphisms, singlenucleotide
  • 相关文献

参考文献4

二级参考文献34

  • 1王悦喜,阿荣,袁托亚.冠心病合并糖尿病患者金属裸支架植入术的治疗效果及安全性评价[J].中国全科医学,2006,9(15):1235-1236. 被引量:13
  • 2Anselmino M,Malmberg K,Ohrvik J,et al.Evidence-based medication and revascularization:powerful tools in the management of patients with diabetes and coronary artery disease:a report from the Euro Heart survey on diabetes and the heart.Eur J Cardiovasc Prey Rehabil,2008,15:216-223.
  • 3Orimo H,Ito H,Suzuki T,et al.Reviewing the definition of " elderly" Geriatrics Gerontol Int,2006,6:149-158.
  • 4Wroblewski B,Glenn MB.The cytochrome P450 drug metabolizing enzyme system:an overview of potential clinicially important drug interactions[J].J Head Trauma Rebabil,2002;17:571-574.
  • 5Wedlund PJ,Aslanian WS,McAllister CB,et al.Mephenytoin hydroxylation deficiency in Caucasians:frequency of a new oxidative drug metabolism polymorphism[J].Clin Pharmacol Ther,1984;36:773-780.
  • 6Wrighton SA,Stevens JC,Becker GW,et al.Isolation and characterization of human liver cytochrome P450 2C19:correlation between 2C19 and S-mephenytoin 4'-hydroxylation[J].Arch Biochem Biophys,1993;306:240-245.
  • 7He N,Yan FX,Huang SL,et al.CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population[J].Eur J Clin Pharmacol,2002;58:15-18.
  • 8Kimura M,Ieiri I,Mamiya K,et al.Genetic Polymorphism of Cytochrome P450s,CYP2C19,and CYP2C9 in a Japanese Population[J].Ther Drug Monit,1998;20:243-247.
  • 9Roh HK,Dahl ML,Tybring G,et al.CYP2C19 genotype and phenotype determined by omeprazole in a Korean population[J].Pharmacogenetics,1996;6:547-551.
  • 10Chang M,Dahl ML,Tybring G,et al.Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians:Comparision with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype[J].Pharmacogenetics,1996;5:358-363.

共引文献123

同被引文献21

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部